Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid. 1989

W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
Diabetes Branch, National Institute of Diabetes, and Digestive and Kidney Diseases, Bethesda, Maryland 20892.

The role of insulin-like growth factor-II (IGF-II) in the hypoglycemia associated with nonislet cell tumors is controversial. In this study we have addressed this question by measuring the IGF-II mRNA levels in extracts of these tumors. Hybridization of a 32P-labeled IGF-II cDNA to a Northern blot of RNA from three nonislet cell tumors associated with hypoglycemia (a hemangiopericytoma, fibrosarcoma, and malignant mesenchymal tumor) demonstrated six hybridizing bands, 6.8, 5.6, 4.7, 3.6, 2.6, and 2.1 kilobases in length. These bands were similar to those described by others in a range of tumors and normal tissues. Tissue IGF-II mRNA levels were quantitated using a solution hybridization/RNase protection assay. IGF-II mRNA levels in the tumors were similar to the level present in one line of human hepatoblastoma-derived Hep G2 cells, 5- to 6-fold higher than that in another line of Hep G2 cells, and 2- to 3-fold higher than that in term placenta. In contrast, little or no IGF-II mRNA was detected in a nonfunctioning islet cell adenoma or normal spleen. There was no evidence for amplification of the IGF-II gene in the one tumor in which it was sought. These data suggest that nonislet cell tumors associated with hypoglycemia produce large amounts of IGF-II mRNA and that this IGF-II mRNA appears to be the product of an IGF-II gene, which is apparently normal in the region encoding mature IGF-II peptide.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
April 1986, Metabolism: clinical and experimental,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
May 1993, Endocrinology,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
October 1991, The Journal of clinical endocrinology and metabolism,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
September 1988, Endocrinology,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
October 1993, Brain research,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
November 1982, The Journal of clinical endocrinology and metabolism,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
April 1991, Endocrinology,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
April 1989, Endocrinology,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
February 1987, Endocrinology,
W L Lowe, and C T Roberts, and D LeRoith, and M T Rojeski, and T J Merimee, and S T Fui, and H Keen, and D Arnold, and J Mersey, and S Gluzman
March 1987, Molecular endocrinology (Baltimore, Md.),
Copied contents to your clipboard!